scispace - formally typeset
P

Paul Gibson

Researcher at University of Calgary

Publications -  29
Citations -  1108

Paul Gibson is an academic researcher from University of Calgary. The author has contributed to research in topics: Pregnancy & Randomized controlled trial. The author has an hindex of 12, co-authored 26 publications receiving 1017 citations.

Papers
More filters
Journal ArticleDOI

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

TL;DR: The current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy is presented.
Journal ArticleDOI

Venous Thromboembolism and Antithrombotic Therapy in Pregnancy

TL;DR: This document presents an approach, based on current evidence, for the diagnosis, treatment, and thromboprophylaxis of venous thromboembolism in pregnancy and postpartum.
Journal ArticleDOI

Herbal and alternative medicine use during pregnancy: a cross-sectional survey

TL;DR: Herbal and alternative medicine use is common among pregnant women and Pregnant women should be asked about their use of these therapies, and further research is needed to clarify the safety and effectiveness ofThese therapies during pregnancy.
Journal ArticleDOI

Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial

TL;DR: There was short-term improvement in the appropriateness of antithrombotic care among patients with NVAF who were exposed to a decision aid, but the improvement did not persist.
Journal ArticleDOI

Venous thromboembolism in pregnancy: 21-year trends.

TL;DR: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity, and relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population is studied.